Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
Class | Active | Resistant |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lineage | Physiology | General | Growth Tolerances | Hydrol./digest./degr. |
|
|
Health: Unknown
Source: soil and water; clinical sources (septicemic infections)
DNA G+C(%): 65-68
|
Opt. T: 32℃
NaCl 3-5%: 3.5(+)
Opt. pH: 6.0
pH 4.2-5.9: 5.0(+)
pH >8: 9.5(+)
|
|
---|
Monosaccharide O/F | Oligosaccharide O/F | Polysaccharide O/F | Polyol O/F | Other O/F |
|
|
|
|
|
---|
Monosaccharide util/assim | Oligosaccharide util/assim | Other carboh. util/assim | Amino acid util/assim | Organic acid util/assim |
|
|
|
|
|
---|
Enzymes: General | Enzymes: Carbohydrate | Enzymes: Protein | Enzymes: Arylamidases | Enzymes: Esters/fats |
|
|
|
|
|
---|
Fuel | Usable Metabolites | Metabolites Released | Special Products | Compounds Produced |
|
---|
Penicillins & Penems (μg/mL) | Cephalosporins (μg/mL) | Aminoglycosides (μg/mL) | Macrolides (μg/mL) | Quinolones (μg/mL) |
ampicillin: R(25; disc)
benzyl-pen: R(10; disc)
penicillin_G: R(1.5U)
imipenem: S(clinic)
|
|
gentamicin: S(clinic)
kanamycin: S(30; disc)
neomycin: Var(MIC50): 10; disc), MIC90: Var(10; disc
streptomycin: Var(MIC50): 10; disc), MIC90: Var(10; disc
|
|
ciprofloxacin: S(clinic)
nalidixic-acid: S(30; disc)
norfloxacin: S(clinic)
pefloxacin: S(clinic)
|
---|---|---|---|---|
Tetracyclines (μg/mL) | Vancomycin Class (μg/mL) | Polypep/ketides (μg/mL) | Heterocycles (μg/mL) | Other (μg/mL) |
chlortetracycline: S(10; disc)
oxytetracycline: S(10; disc)
tetracycline: S(30; disc)
|
|
|
chloramphenicol: Var(MIC50): 10; disc), MIC90: Var(10; disc
nitrofurantoin: S(200; disc)
trimethoprim: S(clinic)
|
colistin: R(10; disc)
vibriostat_129: R(50; disc)
|